Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1198 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80<br />
551. LEMPERT C. The chemistry of the glycocyamidines. Chem Rev 59:<br />
667–736, 1959.<br />
552. LEVI M, BAIRD BM, AND WILSON PV. Cholesterol modulates rat<br />
renal brush border membrane phosphate transport. J Clin Invest<br />
85: 231–237, 1990.<br />
553. LEVILLAIN O, HUS-CITHAREL A, MOREL F, AND BANKIR L.<br />
Arginine synthesis along the mammalian nephron. In: Guanidino<br />
Compounds in Biology <strong>and</strong> Medicine, edited by P. P. De Deyn, B.<br />
Marescau, V. Stalon, <strong>and</strong> I. A. Qureshi. London: Libbey, 1992, p.<br />
63–70.<br />
554. LEVILLAIN O, MARESCAU B, AND DE DEYN PP. Guanidino compound<br />
metabolism in rats subjected to 20% to 90% nephrectomy.<br />
Kidney Int 47: 464–472, 1995.<br />
555. LEVILLAIN O, MARESCAU B, AND DE DEYN PP. Renal h<strong>and</strong>ling<br />
of guanidino compounds in rat <strong>and</strong> rabbit. J Physiol (Lond) 499:<br />
561–570, 1997.<br />
556. LEVINE S, TIKUNOV B, HENSON D, LAMANCA J, AND SWEENEY<br />
HL. <strong>Creatine</strong> depletion elicits structural, biochemical, <strong>and</strong> physiological<br />
adaptations in rat costal diaphragm. Am J Physiol Cell<br />
Physiol 271: C1480–C1486, 1996.<br />
557. LEWIS W AND DALAKAS MC. Mitochondrial toxicity of antiviral<br />
drugs. Nature Med 1: 417–422, 1995.<br />
558. LIAO R, NASCIMBEN L, FRIEDRICH J, GWATHMEY JK, AND<br />
INGWALL JS. Decreased energy reserve in an animal model of<br />
dilated cardiomyopathy. Relationship to contractile performance.<br />
Circ Res 78: 893–902, 1996.<br />
559. LILLIE JW, O’KEEFE M, VALINSKI H, HAMLIN HA, VARBAN ML,<br />
AND KADDURAH-DAOUK R. Cyclocreatine (1-carboxymethyl-2iminoimidazolidine)<br />
inhibits growth of a broad spectrum of cancer<br />
cells derived from solid tumors. Cancer Res 53: 3172–3178,<br />
1993.<br />
560. LILLIE JW, SMEE DF, HUFFMAN JH, HANSEN LJ, SIDWELL RW,<br />
AND KADDURAH-DAOUK R. Cyclocreatine (1-carboxymethyl-2iminoimidazolidine)<br />
inhibits the replication of human herpes viruses.<br />
Antiviral Res 23: 203–218, 1994.<br />
561. LIN D, MEYER DJ, KETTERER B, LANG NP, AND KADLUBAR FF.<br />
Effects of human <strong>and</strong> rat glutathione S-transferases on the covalent<br />
DNA binding of the N-acetoxy derivatives of heterocyclic<br />
amine carcinogens in vitro: a possible mechanism of organ specificity<br />
in their carcinogenesis. Cancer Res 54: 4920–4926, 1994.<br />
562. LIOTTA LA AND STRACKE ML. Tumor invasion <strong>and</strong> metastasis:<br />
biochemical mechanisms. In: Breast Cancer: Cellular <strong>and</strong> Molecular<br />
Biology, edited by M. Lippman <strong>and</strong> R. Dickson. Boston, MA:<br />
Kluwer, 1988, p. 223–238.<br />
563. LIPTON P AND WHITTINGHAM TS. Reduced ATP concentration<br />
as a basis for synaptic transmission failure during hypoxia in the<br />
in vitro guinea-pig hippocampus. J Physiol (Lond) 325: 51–65,<br />
1982.<br />
564. LIRON Z, WONG E, AND ROBERTS E. Studies on uptake of �-aminobutyric<br />
acid by mouse brain particles: toward the development<br />
of a model. Brain Res 444: 119–132, 1988.<br />
565. LIU Q-R, LÓPEZ-CORCUERA B, MANDIYAN S, NELSON H, AND<br />
NELSON N. Molecular characterization of four pharmacologically<br />
distinct �-aminobutyric acid transporters in mouse brain. J Biol<br />
Chem 268: 2106–2112, 1993.<br />
566. LLORETA J, OROZCO M, GEA J, COROMINAS JM, AND SERRANO<br />
S. Selective diaphragmatic mitochondrial abnormalities in a patient<br />
with marked air flow obstruction. Ultrastruct Pathol 20:<br />
67–71, 1996.<br />
567. LLORETA J, ROQUER J, COROMINAS JM, AND SERRANO S.<br />
Hyperthyroid myopathy with mitochondrial paracrystalline rectangular<br />
inclusions. Ultrastruct Pathol 20: 61–65, 1996.<br />
568. LOIKE JD, CAO L, BRETT J, OGAWA S, SILVERSTEIN SC, AND<br />
STERN D. Hypoxia induces glucose transporter expression in<br />
endothelial cells. Am J Physiol Cell Physiol 263: C326–C333, 1992.<br />
569. LOIKE JD, KOZLER VF, AND SILVERSTEIN SC. <strong>Creatine</strong> kinase<br />
expression <strong>and</strong> creatine phosphate accumulation are developmentally<br />
regulated during differentiation of mouse <strong>and</strong> human<br />
monocytes. J Exp Med 159: 746–757, 1984.<br />
570. LOIKE JD, SOMES M, AND SILVERSTEIN SC. <strong>Creatine</strong> uptake,<br />
metabolism, <strong>and</strong> efflux in human monocytes <strong>and</strong> macrophages.<br />
Am J Physiol Cell Physiol 251: C128–C135, 1986.<br />
571. LOIKE JD, ZALUTSKY DL, KABACK E, MIRANDA AF, AND SIL-<br />
VERSTEIN SC. Extracellular creatine regulates creatine transport<br />
in rat <strong>and</strong> human muscle cells. Proc Natl Acad Sci USA 85:<br />
807–811, 1988.<br />
572. LOO G, GOODMAN PJ, HILL KA, AND SMITH JT. <strong>Creatine</strong> metabolism<br />
in the pyridoxine-deficient rat. J Nutr 116: 2403–2408, 1986.<br />
573. LÓPEZ-VILLEGAS D, KIMURA H, TUNLAYADECHANONT S, AND<br />
LENKINSKI RE. High spatial resolution MRI <strong>and</strong> proton MRS of<br />
human frontal cortex. NMR Biomed 9: 297–304, 1996.<br />
574. LOPRESTI P AND COHN M. Direct determination of creatine kinase<br />
equilibrium constants with creatine or cyclocreatine as substrate.<br />
Biochim Biophys Acta 998: 317–320, 1989.<br />
575. LORTET S, HECKMANN M, AUSSEDAT J, RAY A, VINCENT M,<br />
SASSARD J, ZIMMER H-G, AND ROSSI A. Alteration of cardiac<br />
energy state during development of hypertension in rats of the<br />
Lyon strain: a 31 P-NMR study on the isolated rat heart. Acta<br />
Physiol Sc<strong>and</strong> 149: 311–321, 1993.<br />
576. LORTET S, HECKMANN M, RAY A, ROSSI A, AUSSEDAT J,<br />
GRABLY S, AND ZIMMER H-G. Energy metabolism response to<br />
calcium activation in isolated rat hearts during development <strong>and</strong><br />
regression of T 3-induced hypertrophy. Mol Cell Biochem 151: 99–<br />
106, 1995.<br />
577. LOWE JA, MURPHY M, AND NASH V. Changes in plasma <strong>and</strong><br />
muscle creatine concentration after increases in supplementary<br />
dietary creatine in dogs. J Nutr 128: 2691S–2693S, 1998.<br />
578. LUBEC B, AUFRICHT C, HERKNER K, HOEGER H, ADAMIKER<br />
D, GIALAMAS H, FANG-KIRCHER S, AND LUBEC G. <strong>Creatine</strong><br />
reduces collagen accumulation in the kidneys of diabetic db/db<br />
mice. Nephron 67: 214–217, 1994.<br />
579. LUHMANN HJ AND HEINEMANN U. Hypoxia-induced functional<br />
alterations in adult rat neocortex. J Neurophysiol 67: 798–811,<br />
1992.<br />
580. LUTOSLAWSKA G AND BAER HP. <strong>Creatine</strong> phosphate inhibition<br />
of heart 5�-nucleotidase appears due to contaminants. Experientia<br />
39: 1358–1359, 1983.<br />
581. MACALLISTER RJ, WHITLEY GSJ, AND VALLANCE P. Effects of<br />
guanidino <strong>and</strong> uremic compounds on nitric oxide pathways. Kidney<br />
Int 45: 737–742, 1994.<br />
582. MADARAS MB AND BUCK RP. Miniaturized biosensors employing<br />
electropolymerized permselective films <strong>and</strong> their use for creatinine<br />
assays in human serum. Anal Chem 68: 3832–3839, 1996.<br />
583. MAGANARIS CN AND MAUGHAN RJ. <strong>Creatine</strong> supplementation<br />
enhances maximum voluntary isometric force <strong>and</strong> endurance capacity<br />
in resistance trained men. Acta Physiol Sc<strong>and</strong> 163: 279–<br />
287, 1998.<br />
584. MAHANNA DA, FITCH CD, AND FISCHER VW. Effects of �-guanidinopropionic<br />
acid on murine skeletal muscle. Exp Neurol 68:<br />
114–121, 1980.<br />
585. MAHLER M. Control of oxygen consumption in normal <strong>and</strong> dystrophic<br />
skeletal muscle. In: Heart <strong>Creatine</strong> Kinase, edited by<br />
W. E. Jacobus <strong>and</strong> J. S. Ingwall. Baltimore, MD: Williams &<br />
Wilkins, 1980, p. 92–108.<br />
586. MAIER M, RON MA, BARKER GJ, AND TOFTS PS. Proton magnetic<br />
resonance spectroscopy: an in vivo method of estimating<br />
hippocampal neuronal depletion in schizophrenia. Psychol Med<br />
25: 1201–1209, 1995.<br />
587. MAKINO H, ISHIZAKA Y, TSUJIMOTO A, NAKAMURA T, ONDA<br />
M, SUGIMURA T, AND NAGAO M. Rat p53 gene mutations in<br />
primary Zimbal gl<strong>and</strong> tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline,<br />
a food mutagen. Proc Natl Acad Sci USA 89:<br />
4850–4854, 1992.<br />
588. MAKINO H, USHIJIMA T, KAKIUCHI H, ONDA M, ITO N, SUG-<br />
IMURA T, AND NAGAO M. Absence of p53 mutations in rat colon<br />
tumors induced by 2-amino-6-methyldipyrido[1,2-a:3�,2�-d]imidazole,<br />
2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1methyl-6-phenylimidazo[4,5-b]pyridine.<br />
Jpn J Cancer Res 85: 510–<br />
514, 1994.<br />
589. MALAVEILLE C, HAUTEFEUILLE A, PIGNATELLI B, TALASKA<br />
G, VINEIS P, AND BARTSCH H. Dietary phenolics as anti-mutagens<br />
<strong>and</strong> inhibitors of tobacco-related DNA adduction in the urothelium<br />
of smokers. Carcinogenesis 17: 2193–2200, 1996.<br />
590. MALFATTI MA, BUONARATI MH, TURTELTAUB KW, SHEN NH,<br />
AND FELTON JS. The role of sulfation <strong>and</strong>/or acetylation in the<br />
metabolism of the cooked-food mutagen 2-amino-1-methyl-6-phe-